The rating affirmation is based on a number of factors, including Halifax Health’s steady operating results and leading market share in its primary service area.
The outlook is stable.
Fitch has also affirmed Halifax Health’s following bonds:
- $115.1 million of series 2015 bonds at “BBB+”
- $42.7 million of series 2006A bonds at “BBB+”
- $107.9 million of series 2006B-1 and B-2 bonds at “BBB+”
- $70 million of series 2008 bonds at “BBB+”
More articles on healthcare finance:
RelayHealth financial reports 1.6% ICD-10 denial rate, MedAssets-Precyse launches new platform & more — 11 RCM key notes
California hospital to close after restructuring plan fails
From volume to value: The rules of the comprehensive joint replacement bundle
